Unity Biotechnology
UBX
$1.61
Share price
-1.23%
Change (1 day)
-29.39%
Change (1 year)
Categories
Unity Biotechnology (UBX) - Cash on Hand
Cash on Hand as of December 2023 : $43.2 M
According to Unity Biotechnology
's latest financial reports the company has $43.2 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Unity Biotechnology - Cash on Hand chart (from 2017 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $94.79 M | 7.63% |
| 2021-12-31 | $88.07 M | -9.85% |
| 2020-12-31 | $97.69 M | -23.37% |
| 2019-12-31 | $0.12 B | -25.5% |
| 2018-12-31 | $0.17 B | 97.82% |
| 2017-12-31 | $86.51 M | -3.11% |
| 2016-12-31 | $89.28 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 381.90% | 🇺🇸 USA |